Roper Technologies (NASDAQ:ROP) late Wednesday was rated Buy in new research coverage by analysts at financial-services firm ...

As part of the acquisition, CentralReach will remain independent, preserving its team, brands, products and mission.

Roper Technologies agreed to acquire healthcare technology company CentralReach from Insight Partners for about $1.65 billion ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $627.14, a high ...

Roper Technologies (ROP) has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase ...

CentralReach, a Holmdel company whose software is used to treat people diagnosed with autism, has been sold for $1.85 billion ...

Stifel initiated coverage of Roper Technologies (ROP) with a Buy rating and $685 price target Roper concentrates its investments on ...

Fintel reports that on March 27, 2025, Stifel initiated coverage of Roper Technologies (NasdaqGS:ROP) with a Buy recommendation. Analyst Price Forecast Suggests 10.40% Upside As of March 18, 2025, the ...

Roper Technologies, which posted $7.04 billion in revenue in 2024, expects Fort Lauderdale-based CentralReach to contribute ...

CentralReach is a leading provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis (“ABA”) therapy. Over 200,000 professionals utilize CentralReach’s ...

Roper Technologies to acquire CentralReach for $1.65 billion, expects 20%+ organic revenue growth and plans to integrate into ...

ROP's acquisition of CentralReach will enable it to strengthen its product offerings and boost its Application Software segment.